MX360674B - Vesiculas que comprenden factor de crecimiento epidermico y composiciones que las contienen. - Google Patents

Vesiculas que comprenden factor de crecimiento epidermico y composiciones que las contienen.

Info

Publication number
MX360674B
MX360674B MX2015001561A MX2015001561A MX360674B MX 360674 B MX360674 B MX 360674B MX 2015001561 A MX2015001561 A MX 2015001561A MX 2015001561 A MX2015001561 A MX 2015001561A MX 360674 B MX360674 B MX 360674B
Authority
MX
Mexico
Prior art keywords
vesicles
growth factor
epidermal growth
compositions
include epidermal
Prior art date
Application number
MX2015001561A
Other languages
English (en)
Other versions
MX2015001561A (es
Inventor
Díaz Eduardo Martínez
Acosta Jorge Amador Berlanga
Milián Héctor Jesús Santana
Rull Leonor Ventosa
Puig Ingrid Cabrera
Miró Jaume Veciana
Original Assignee
Ct Ingenieria Genetica Biotecnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49118249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX360674(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ct Ingenieria Genetica Biotecnologia filed Critical Ct Ingenieria Genetica Biotecnologia
Publication of MX2015001561A publication Critical patent/MX2015001561A/es
Publication of MX360674B publication Critical patent/MX360674B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)

Abstract

La presente invención se refiere a vesículas que comprenden el Factor de Crecimiento Epidérmico (EGF), un surfactante catiónico, y colesterol o sus derivados; la invención también revela un procedimiento para su preparación, basado en la tecnología de fluidos comprimidos (FCs); las vesículas de la invención tienen utilidad en la fabricación de medicamentos y productos cosméticos, y en la ingeniería tisular.
MX2015001561A 2012-08-02 2013-08-02 Vesiculas que comprenden factor de crecimiento epidermico y composiciones que las contienen. MX360674B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CUP2012000112A CU24121B1 (es) 2012-08-02 2012-08-02 Vesículas que comprenden factor de crecimiento epidérmico y composiciones que las contienen
PCT/CU2013/000004 WO2014019555A1 (es) 2012-08-02 2013-08-02 Vesiculas que comprenden factor de crecimiento epidermico y composiciones que las contienen

Publications (2)

Publication Number Publication Date
MX2015001561A MX2015001561A (es) 2015-09-29
MX360674B true MX360674B (es) 2018-11-13

Family

ID=49118249

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015001561A MX360674B (es) 2012-08-02 2013-08-02 Vesiculas que comprenden factor de crecimiento epidermico y composiciones que las contienen.

Country Status (27)

Country Link
US (2) US9717776B2 (es)
EP (1) EP2915541B1 (es)
JP (1) JP6251740B2 (es)
KR (1) KR101752757B1 (es)
CN (1) CN104684575B (es)
AR (1) AR091951A1 (es)
AU (1) AU2013299036C1 (es)
BR (1) BR112015002103B1 (es)
CA (1) CA2880404C (es)
CL (1) CL2015000254A1 (es)
CU (1) CU24121B1 (es)
DK (1) DK2915541T3 (es)
ES (1) ES2613087T3 (es)
HK (1) HK1210970A1 (es)
HR (1) HRP20170145T1 (es)
HU (1) HUE033286T2 (es)
MX (1) MX360674B (es)
MY (1) MY196771A (es)
PL (1) PL2915541T3 (es)
PT (1) PT2915541T (es)
RS (1) RS55713B1 (es)
RU (1) RU2649781C2 (es)
SG (1) SG11201500797SA (es)
SI (1) SI2915541T1 (es)
UA (1) UA113448C2 (es)
WO (1) WO2014019555A1 (es)
ZA (1) ZA201500763B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3241565A4 (en) * 2014-12-30 2018-07-18 Celltrion, Inc. Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
EP3270984A4 (en) * 2015-03-16 2019-04-17 Duncan Ross TREATMENT METHOD WITH MEMBRANE-INCLUDED VESICLE
WO2017123022A1 (ko) * 2016-01-12 2017-07-20 주식회사 강스템바이오텍 고함량의 성장인자를 함유한 줄기세포 유래 엑소좀
WO2017147407A1 (en) 2016-02-25 2017-08-31 Board Of Regents, The University Of Texas System Compositions comprising composite nanocarriers and methods of making and uses thereof
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
TWI636794B (zh) * 2017-11-06 2018-10-01 吳治增 一種奈米複合材料及其應用
CU20190022A7 (es) * 2019-03-18 2020-10-20 Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma Composición farmacéutica para el tratamiento de la úlcera del pie diabético
WO2021206328A1 (ko) * 2020-04-10 2021-10-14 한국과학기술연구원 신규 재조합 엑소좀 및 그의 용도
CN113827622B (zh) * 2021-08-31 2023-11-07 南方医科大学 奇异变形杆菌外膜囊泡在制备预防或治疗骨溶解性疾病药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0272123A (ja) * 1988-09-07 1990-03-12 Hitachi Chem Co Ltd ヒト上皮細胞成長因子の投与方法及びヒト上皮細胞成長因子含有疾病治療剤
US4944948A (en) 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US5618544A (en) 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US20020081324A1 (en) * 2002-01-22 2002-06-27 Twine Rebecca Wright Method of treating aging skin and wrinkles using a combination of growth factors that is commercially prepared or derived from one's own blood
AU2003222668A1 (en) * 2002-04-25 2003-11-10 Rapidheal, Inc. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
ES2265262B1 (es) * 2005-01-31 2008-03-01 Activery Biotech, S.L.(Titular Al 50%) Procedimiento para la obtencion de sistemas micro- y nanodispersos.
WO2007065464A1 (en) 2005-12-09 2007-06-14 Stichting Katholieke Universiteit Epidermal growth factor (egf) derivatives with selectable selectivity for the erb receptor family
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
JP2009234945A (ja) * 2008-03-26 2009-10-15 Shalom:Kk ｈ−ＥＧＦ含有スフィンゴミエリンリポソームおよびこれを配合した化粧料及び医薬品
CN102091034A (zh) * 2009-12-15 2011-06-15 哈尔滨工业大学 基于胆固醇衍生物的有机-无机复合纳米囊泡的制备
KR101102834B1 (ko) * 2010-02-24 2012-01-05 충남대학교산학협력단 신규한 리포좀 제조 방법 및 장치
WO2011138687A2 (en) * 2010-05-06 2011-11-10 Regenics As Use of cellular extracts for skin rejuvenation

Also Published As

Publication number Publication date
SG11201500797SA (en) 2015-03-30
AU2013299036B2 (en) 2017-12-14
CA2880404C (en) 2018-02-13
CL2015000254A1 (es) 2015-10-16
AU2013299036A1 (en) 2015-03-19
AR091951A1 (es) 2015-03-11
CU20120112A7 (es) 2014-03-26
HRP20170145T1 (hr) 2017-04-07
DK2915541T3 (en) 2017-02-13
JP6251740B2 (ja) 2017-12-20
HK1210970A1 (en) 2016-05-13
JP2015527337A (ja) 2015-09-17
MY196771A (en) 2023-05-03
BR112015002103B1 (pt) 2022-11-29
SI2915541T1 (sl) 2017-05-31
RU2015106683A (ru) 2016-09-27
KR20150041795A (ko) 2015-04-17
PT2915541T (pt) 2017-02-13
CN104684575B (zh) 2018-07-31
US9717776B2 (en) 2017-08-01
MX2015001561A (es) 2015-09-29
CN104684575A (zh) 2015-06-03
CA2880404A1 (en) 2014-02-06
PL2915541T3 (pl) 2017-06-30
BR112015002103A2 (pt) 2019-08-20
KR101752757B1 (ko) 2017-07-04
WO2014019555A1 (es) 2014-02-06
US20180015145A1 (en) 2018-01-18
ES2613087T3 (es) 2017-05-22
UA113448C2 (xx) 2017-01-25
AU2013299036C1 (en) 2018-03-29
RS55713B1 (sr) 2017-07-31
ZA201500763B (en) 2016-01-27
US20150182590A1 (en) 2015-07-02
HUE033286T2 (en) 2017-11-28
US11510965B2 (en) 2022-11-29
RU2649781C2 (ru) 2018-04-04
EP2915541A1 (en) 2015-09-09
EP2915541B1 (en) 2016-11-09
CU24121B1 (es) 2015-08-27

Similar Documents

Publication Publication Date Title
MX2015001561A (es) Vesiculas que comprenden factor de crecimiento epidermico y composiciones que las contienen.
EP3354257A4 (en) COMPOSITION FOR IMPROVING SKIN AND PREVENTING HAIR LOSS WITH EXTRACELLULAR VESICLES FROM PLANT EXTRACTS
WO2013177421A3 (en) Lipid-coated albumin nanoparticle compositions and methods of making and method of using the same
MY183637A (en) Compounds and uses thereof for the modulation of hemoglobin
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
IN2012DN01269A (es)
BR112014026038A2 (pt) propante modificado, formulação de fraturamento hidráulico, método de fraturamento de um poço, método de produção de um propante modificado e método de produção de um propante revestido com hidrogel
RS55739B1 (sr) Novi derivati indolizina, postupak njihove proizvodnje i farmaceutske kompozicije koje ih sadrže za lečenje kancera
WO2011130615A3 (en) Preparation of lacosamide
MX2013001402A (es) Proceso para preparar tubulisinas.
HK1197414A1 (zh) 雌甾- -四烯- -甲酰胺衍生物、其製備方法、包含其的藥物製劑及其用於製備藥物的用途
WO2012007214A3 (de) Haarkonditionierende zusammensetzungen
MX2013009531A (es) Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
IL246525B (en) Pomegranate cell culture and methods for its preparation and use
MX2014014517A (es) Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado.
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
WO2012031987A3 (de) Octenidindihydrochlorid als co-emulgator in mikroemulsionen
WO2013121279A3 (en) Process to prepare ertapenem
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
MX2012007599A (es) Composiciones para formar peliculas que tienen un grado deseado de cobertura y metodos para hacer y usar las mismas.
MX2013003859A (es) Polimorfos de picropodofilina b o c para su uso en la terapia del cancer.
AU2013338098A8 (en) Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
WO2012163469A3 (de) Extrakte aus eugenia uniflora
AU2016286071A8 (en) Total synthesis of shishijimicin A and analogs thereof

Legal Events

Date Code Title Description
FG Grant or registration